南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

赞沙替尼(Xanthatin)直接作用于ZDHHC7,抑制NLRP3的棕榈酰化反应及炎症小体激活,从而缓解脓毒症及急性肺损伤症状。

Xanthatin directly targets ZDHHC7 to inhibit NLRP3 palmitoylation and inflammasome activation, alleviating sepsis and acute lung injury

Xu Xiangwei, Li Weifeng, Wei Zhihui, Huang Mincong, Zheng Zhiwei, Lin Li, Xu Haowen, Liang Guang

Journal:Cell Communication and Signaling

IF:11.6

DOI:10.1186/s12964-026-03225-z

PMID:

Published:2026-09-17

research field:翻译后修饰固有免疫药物发现炎症性疾病化学蛋白质组学

Abstract

Aberrant activation of the NLRP3 inflammasome drives the pathogenesis of diverse inflammatory diseases, including acute respiratory distress syndrome (ARDS) and sepsis. Among the post-translational modifications regulating NLRP3, S-palmitoylation contributes to NLRP3 localization and inflammasome assembly, but pharmacological modulators of this process remain limited. Here, we identified that Xanthatin, a bioactive sesquiterpene lactone, as a potential and specific inhibitory activity against NLRP3 inflammasome activation. Xanthatin dose-dependently suppressed IL-1β maturation and pyroptosis in both murine and human macrophages, with an IC 50 of approximately 2.09 µM. Mechanistically, Xanthatin specifically blocked the assembly of the NLRP3 inflammasome complex. Using a chemoproteomic strategy combining cellular thermal shift assay with mass spectrometry, we identified the palmitoyltransferase ZDHHC7 as a molecular target engaged by Xanthatin. We demonstrated that Xanthatin binds to ZDHHC7, thereby abrogating the ZDHHC7-mediated palmitoylation of NLRP3 and its subsequent interaction with apoptosis-associated speck-like protein containing a CARD (ASC). In vivo, Xanthatin treatment significantly attenuated ARDS, peritonitis, and sepsis in mouse models. However, it conferred no additional therapeutic benefit in Nlrp3 ⁻ /⁻ mice. Collectively, this study presents Xanthatin as the first-in-class lead compound for developing palmitoyltransferase ZDHHC7 inhibition and elucidates the ZDHHC7 as a promising pharmacological target for the treatment of NLRP3-driven inflammatory diseases. Graphical

本文使用的Yeasen产品

购物车
客服
转染试用